[ M2i Life Sciences raises $13M in funding ]
M2i Life Sciences has raised $13 million in funding.
Founded in 2013, M2i Life Sciences is an expert in the design, formulation and production of complex molecules. It develops pheromones for crop protection, animal health and human health, producing agricultural chemical products in the Biocontrol sector, which address the issue of tackling increasing resistance and toxicity of insecticides and GMOs with a new generation of natural solutions.
The new financing will be used to enable biocontrol producer M2i to finance the approval process of its Biocontrol products, pursue its R&D investment strategy and accelerate its international development.
|Founder / CEO||Philippe Guerret|